chr19-13235199-C-T

Variant names:

• chr19-13235199-C-T
• rs369033909
• NM_001127222.2:c.5133+10G>A

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_Strong BP6 BS1 BS2

The NM_001127222.2(CACNA1A):​c.5133+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000306 in 1,606,702 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

• Frequency:
  • Genomes: 𝑓 0.00032 (1 hom., cov: 32)
  • Exomes 𝑓: 0.00031 (1 hom.)
• Consequence: CACNA1A NM_001127222.2 intron
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1 B:2
• Conservation: PhyloP100: -4.65

Genes affected

CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]

ACMG classification

Verdict is Benign. Variant got -13 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.96).
• BP6: Variant 19-13235199-C-T is Benign according to our data. Variant chr19-13235199-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 283174.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Benign=1, Uncertain_significance=1}.
• BS1: Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000315 (48/152260) while in subpopulation AMR AF= 0.0019 (29/15300). AF 95% confidence interval is 0.00136. There are 1 homozygotes in gnomad4. There are 23 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
• BS2: High AC in GnomAd4 at 48 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CACNA1A	NM_001127222.2	c.5133+10G>A		intron_variant	Intron 33 of 46	ENST00000360228.11	NP_001120694.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CACNA1A	ENST00000360228.11	c.5133+10G>A		intron_variant	Intron 33 of 46	1	NM_001127222.2	ENSP00000353362.5
CACNA1A	ENST00000638029.1	c.5151+10G>A		intron_variant	Intron 34 of 47	5		ENSP00000489829.1
CACNA1A	ENST00000573710.7	c.5139+10G>A		intron_variant	Intron 33 of 46	5		ENSP00000460092.3
CACNA1A	ENST00000635727.1	c.5136+10G>A		intron_variant	Intron 33 of 46	5		ENSP00000490001.1
CACNA1A	ENST00000637769.1	c.5136+10G>A		intron_variant	Intron 33 of 46	1		ENSP00000489778.1
CACNA1A	ENST00000636012.1	c.5136+10G>A		intron_variant	Intron 33 of 45	5		ENSP00000490223.1
CACNA1A	ENST00000637736.1	c.4995+10G>A		intron_variant	Intron 32 of 45	5		ENSP00000489861.1
CACNA1A	ENST00000636389.1	c.5136+10G>A		intron_variant	Intron 33 of 46	5		ENSP00000489992.1
CACNA1A	ENST00000637432.1	c.5151+10G>A		intron_variant	Intron 34 of 47	5		ENSP00000490617.1
CACNA1A	ENST00000636549.1	c.5142+10G>A		intron_variant	Intron 34 of 47	5		ENSP00000490578.1
CACNA1A	ENST00000637927.1	c.5139+10G>A		intron_variant	Intron 33 of 46	5		ENSP00000489715.1
CACNA1A	ENST00000635895.1	c.5136+10G>A		intron_variant	Intron 33 of 46	5		ENSP00000490323.1
CACNA1A	ENST00000638009.2	c.5136+10G>A		intron_variant	Intron 33 of 46	1		ENSP00000489913.1
CACNA1A	ENST00000637276.1	c.5136+10G>A		intron_variant	Intron 33 of 45	5		ENSP00000489777.1

Frequencies

GnomAD3 genomes AF: 0.000315 AC: 48 AN: 152142 Hom.: 1 Cov.: 32

Gnomad AFR AF: 0.0000966

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00190

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.0000943

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.000191

Gnomad OTH AF: 0.000478

GnomAD3 exomes AF: 0.000560 AC: 132 AN: 235706 Hom.: 0 AF XY: 0.000438 AC XY: 56 AN XY: 127824

Gnomad AFR exome AF: 0.000278

Gnomad AMR exome AF: 0.00248

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.000170

Gnomad FIN exome AF: 0.0000476

Gnomad NFE exome AF: 0.000273

Gnomad OTH exome AF: 0.00223

GnomAD4 exome AF: 0.000305 AC: 444 AN: 1454442 Hom.: 1 Cov.: 31 AF XY: 0.000277 AC XY: 200 AN XY: 723048

Gnomad4 AFR exome AF: 0.000180

Gnomad4 AMR exome AF: 0.00242

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.000203

Gnomad4 SAS exome AF: 0.000211

Gnomad4 FIN exome AF: 0.0000754

Gnomad4 NFE exome AF: 0.000252

Gnomad4 OTH exome AF: 0.000415

GnomAD4 genome AF: 0.000315 AC: 48 AN: 152260 Hom.: 1 Cov.: 32 AF XY: 0.000309 AC XY: 23 AN XY: 74440

Gnomad4 AFR AF: 0.0000963

Gnomad4 AMR AF: 0.00190

Gnomad4 ASJ AF: 0.00

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.00

Gnomad4 FIN AF: 0.0000943

Gnomad4 NFE AF: 0.000191

Gnomad4 OTH AF: 0.000473

Alfa AF: 0.000277 Hom.: 0

Bravo AF: 0.000495

Asia WGS AF: 0.000289 AC: 1 AN: 3478

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:1 Benign:2

Revision: criteria provided, conflicting classifications

Submissions by phenotype

not provided Uncertain:1

Oct 24, 2017

Eurofins Ntd Llc (ga)

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

not specified Benign:1

Dec 04, 2017

GeneDx

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1

Feb 01, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.96
CADD	Benign	0.050
DANN	Benign	0.27

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs369033909; hg19: chr19-13346013; COSMIC: COSV64212550; COSMIC: COSV64212550;